NCI's Research on COVID-19, Vaccines, and Antibodies - NCI
![](https://www.cancer.gov/sites/g/files/xnrzdm211/files/styles/cgov_social_media/public/cgov_image/media_image/2021-08/Coronavirus%20infected%20cells-NIAID.jpg)
What are COVID-19 antibodies, is there a certain level needed for protection, and how well do COVID-19 vaccines work in people with cancer? In this Q&A, NCI experts discuss emerging research findings from the SeroNet program that are shedding light on these and other important questions.
![](https://www.reuters.com/resizer/v2/https%3A%2F%2Fcloudfront-us-east-2.images.arcpublishing.com%2Freuters%2FQ4DBZTPYRVP4ZCW7CAUZRLJYJ4.jpg?auth=81ad07e13ba450fc4d6345c14afcf4c0b5e8857a6c012c61d46787f4172cdb0b&width=1920&height=2400&smart=true)
COVID SCIENCE Oxygen level while walking identifies at-risk patients; cancer patients should get vaccine priority
![](https://medicine.wustl.edu/wp-content/uploads/covid-vax-bottle.jpeg)
Antibodies and Vaccines as Drugs for COVID-19, keystone symposia
National Cancer Institute (NCI) on LinkedIn: Study Identifies Crucial Characteristic of High-Risk HPV
![](https://www.cancer.gov/sites/g/files/xnrzdm211/files/styles/cgov_featured/public/cgov_image/media_image/2020-04/response-to-COVID-19.jpg?h=d7d42d26&itok=-_1qUf_q)
NCI's Research on COVID-19, Vaccines, and Antibodies - NCI
![](https://www.sec.gov/Archives/edgar/data/1472091/000114036122012244/image0001.jpg)
image0001.jpg
![](https://directorsblog.nih.gov/wp-content/uploads/2021/12/antibody-counts-full-1024x576.jpg)
neutralizing antibodies – NIH Director's Blog
![](https://www.ualberta.ca/folio/media-library/2023/01/230119-covid-vaccine-transplant-main-16x9-3000px.jpg)
New U of A-based study to examine very rare adverse events linked to COVID-19 vaccines
![](https://www.aacr.org/wp-content/uploads/2022/02/2110048Q_C19CR_Sidebars_Full_16-scaled.jpg)
Cancer in the Midst of COVID-19, A Report
![](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-020-01194-5/MediaObjects/41591_2020_1194_Fig1_HTML.png)
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
![](https://www.futuremedicine.com/cms/10.2217/nnm-2020-0286/asset/images/medium/figure2.gif)
No small matter: a perspective on nanotechnology-enabled solutions to fight COVID-19